PARAGARD T380A Rx
Generic Name and Formulations:
Copper-bearing intrauterine contraceptive device.
The Cooper Companies
Indications for PARAGARD T380A:
See literature. ≥16yrs: Insert into uterine cavity. Check placement shortly after first menses. Replace at least every 10 years.
<16yrs: not recommended.
Uterine abnormality. Uterine or cervical malignancy. Pelvic inflammatory disease or risk thereof. Postpartum or postabortal endometritis in the past 3 months. Genital actinomycosis. Abnormal genital bleeding. Cervicitis. Wilson's disease. Retained IUD. Pregnancy or suspicion of pregnancy.
Vaginal bleeding. Ectopic pregnancy. Immunocompromised. Immunosuppressive therapy. Avoid medical diathermy. Assure suitable uterine anatomy before insertion. Remove the device if evidence of partial expulsion, perforation, or breakage.
Bleeding, cramps, anemia, dyspareunia, pelvic infection, infertility, ectopic pregnancy, uterine or cervical perforation, embedment or fragmentation of device, septicemia (during pregnancy), spontaneous abortion, vasovagal reactions (during insertion or removal).
Clinical Pain Advisor Articles
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Greater Temporal Summation of Pain in HIV With Chronic Pain
- FDA Warns Two Companies About Bogus Opioid Addiction Treatment
- Prescription Digital Therapeutic Approved for Opioid Use Disorder
- A Potential Biomarker for Predicting Antibody Treatment Efficacy in Migraine